Is Nitroglycerin Ointment (Rectiv) in shortage?
Nitroglycerin Ointment is listed by FDA as being discontinued by at least one maker (updated Apr 14, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Rectiv, Ointment, 0.4% (NDC 58914-301-80)
Discontinuation of the manufacture of the drug
Maker contact: 800-678-1605
FDA recalls of Nitroglycerin
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Nitroglycerin Ointment:
- Glenmark Pharmaceuticals Inc., USA recalls Nitroglycerin Sublingual Tablets 0.3MG, 100-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited,
- Glenmark Pharmaceuticals Inc., USA recalls Nitroglycerin Sublingual Tablets 0.4MG 100-count carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,
- Padagis US LLC recalls Nitroglycerin Lingual Spray, 400 mcg per spray, 200 metered sprays, 12 g bottles, Rx only, Manufactured by Perrigo,
- Cardinal Health Inc. recalls Rectiv (nitroglycerin) Ointment 0.4% For Intra-anal Use Only 30 g Rx Only NDC 58914-301-80 Mfd. by: Pharbil Waltrop
- Baxter Healthcare Corp. recalls 50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), 250 mL glass containers, Baxter Healthcare Corp., Deerfield,
Nitroglycerin Ointment shortage questions
Is Nitroglycerin Ointment (Rectiv) in shortage?
Nitroglycerin Ointment is listed by FDA as being discontinued by at least one maker (updated Apr 14, 2026).
What should I do if I can’t get Nitroglycerin Ointment?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.